California 2023-2024 Regular Session

California Senate Bill SB1213

Introduced
2/15/24  
Introduced
2/15/24  
Refer
2/29/24  
Refer
2/29/24  
Refer
3/21/24  
Refer
3/21/24  
Report Pass
4/4/24  
Refer
4/4/24  
Refer
4/4/24  
Refer
4/8/24  
Refer
4/8/24  
Report Pass
5/16/24  
Report Pass
5/16/24  
Engrossed
5/21/24  
Engrossed
5/21/24  
Refer
5/28/24  
Report Pass
6/5/24  
Report Pass
6/5/24  
Refer
6/5/24  
Refer
6/5/24  
Report Pass
8/15/24  
Report Pass
8/15/24  
Enrolled
8/30/24  
Enrolled
8/30/24  
Vetoed
9/27/24  

Caption

Health care programs: cancer.

Impact

The potential impact of SB 1213 is significant, particularly for low-income individuals at risk of breast and cervical cancer. By increasing the income eligibility threshold, SB 1213 aims to broaden access to essential health services provided under the federal Centers for Disease Control and Prevention's early detection program. This change reflects a more inclusive approach to public health, ensuring that a greater number of individuals can access necessary screenings and treatments. The expansion may lead to earlier detection of cancers, ultimately improving health outcomes for thousands of Californians.

Summary

Senate Bill 1213, introduced by Senator Atkins, focuses on enhancing eligibility for health care programs specifically aimed at cancer screening and treatment. The bill amends Sections 104150 and 104162 of the Health and Safety Code to expand access to breast and cervical cancer services for low-income individuals. It extends the income threshold for eligibility from 200% to 250% of the federal poverty level, which is scheduled to take effect no later than July 1, 2026. This amendment is intended to address the growing needs of Californians requiring accessible cancer care amidst rising healthcare costs.

Sentiment

The sentiment surrounding SB 1213 appears largely positive, as it demonstrates a commitment to improving public health provisions for vulnerable populations. Supporters of the bill, including health advocacy groups and public health officials, argue that the increased eligibility will aid in identifying and treating cancer earlier, thereby decreasing mortality rates. However, there may be some contention regarding the costs associated with expanding these programs and whether state funding can sufficiently cover the anticipated increase in screenings and treatments. Overall, the support for early cancer detection bolsters the bill's case.

Contention

Notably, some concerns have been raised about the sustainability of funding for the expanded eligibility under SB 1213. Critics may question whether the state can handle the increased demand for services without compromising the quality of care. Additionally, the bill may face scrutiny in terms of its implications for the existing Medi-Cal program and its operational capacity to manage an influx of new beneficiaries. Discourse around the bill could reflect broader discussions about healthcare funding and the balance between accessibility and financial feasibility.

Companion Bills

No companion bills found.

Similar Bills

CA AB2100

Medi-Cal: pharmacy benefits.

CA AB2055

Specialty mental health services and substance use disorder treatment.

CA AB120

Budget Act of 2017.

CA SB105

Budget Act of 2017.

CA SB310

Unused medications: cancer medication recycling.

CA AB415

CalFresh: employment social enterprises.

CA SB521

Drug manufacturers: value-based arrangement.

CT SB00010

An Act Promoting Access To Affordable Prescription Drugs, Health Care Coverage, Transparency In Health Care Costs, Home And Community-based Support For Vulnerable Persons And Rights Regarding Gender Identity And Expression.